The rate-limiting enzyme of the mevalonate pathway, 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, provides essential intermediates for the prenylation of nuclear lamins and Ras and dolichol-mediated glycosylation of growth factor receptors. The diterpene geranylgeraniol downregulates the level of HMG CoA reductase and suppresses the growth of human liver, lung, ovary, pancreas, colon, stomach, and blood tumors. We evaluated the growth-suppressive activity of geranylgeraniol in human prostate carcinoma cells. Geranylgeraniol induced dose-dependent suppression of the viability of human DU145 prostate carcinoma cells (IC50 = 80 ± 18 µmol/L, n = 5) following 72-h incubations in 96-well plates. Cell cycle was arrested at the G1 phase with a concomitant decrease in cyclin D1 protein. Geranylgeraniol-induced apoptosis was detected by flow cytometric analysis, fluorescence microscopy following acridine orange and ethidium bromide dual staining, and caspase-3 activation. Geranylgeraniol-induced viability suppression was accompanied by concentration-dependent decrease in the level of HMG CoA reductase protein. As a nonsterol molecule that downregulates HMG CoA reductase in the presence of sterols, geranylgeraniol may have potential in the chemoprevention and/or therapy of human prostate cancer.
BachTJ. Some new aspects of isoprenoid biosynthesis in plants–a review. Lipids1995; 30: 191–202.
2.
MoHElsonCE. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood)2004; 229: 567–85.
3.
GoldsteinJLBrownMS. Regulation of the mevalonate pathway. Nature1990; 343: 425–30.
4.
MeigsTERosemanDSSimoniRD. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation by the nonsterol mevalonate metabolite farnesol in vivo. J Biol Chem1996; 271: 7916–22.
5.
SeverNSongBLYabeDGoldsteinJLBrownMSDeBose-BoydRA. Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol. J Biol Chem2003; 278: 52479–90.
6.
KaturuRFernandesNVElfakhaniMDuttaDMillsNHyndsDLKingCMoH. Mevalonate depletion mediates the suppressive impact of geranylgeraniol on murine B16 melanoma cells. Exp Biol Med (Maywood)2011; 236: 604–13.
7.
GraafMRBeiderbeckABEgbertsACRichelDJGuchelaarHJ. The risk of cancer in users of statins. J Clin Oncol2004; 22: 2388–94.
8.
OsmakM. Statins and cancer: current and future prospects. Cancer Lett2012; 324: 1–12.
9.
KrycerJRPhanLBrownAJ. A key regulator of cholesterol homeostasis, SREBP-2, can be targeted in prostate cancer cells with natural products. Biochem J2012; 446: 191–201.
10.
FernandesNJungMDaoudAMoH. Biphenylalkylacetylhydroquinone ethers suppress the proliferation of murine B16 melanoma cells. Anticancer Res2008; 28: 1005–12.
11.
HusseinDMoH. d-δ-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa2 and BxPC-3 pancreatic carcinoma cells. Pancreas2009; 38: e124–36.
12.
AndreeHAReutelingspergerCPHauptmannRHemkerHCHermensWTWillemsGM. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem1990; 265: 4923–8.
13.
FadokVAVoelkerDRCampbellPACohenJJBrattonDLHensonPM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol1992; 148: 2207–16.
14.
SeverNYangTBrownMSGoldsteinJLDeBose-BoydRA. Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol Cell2003; 11: 25–33.
15.
MassagueJ. G1 cell-cycle control and cancer. Nature2004; 432: 298–306.
16.
FernandesNVGuntipalliPKMoH. d-δ-Tocotrienol-mediated cell cycle arrest and apoptosis in human melanoma cells. Anticancer Res2010; 30: 4937–44.
17.
DeBose-BoydRA. Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res2008; 18: 609–21.
18.
TakedaYNakaoKNakataKKawakamiAIdaHIchikawaTShigenoMKajiyaYHamasakiKKatoYEguchiK. Geranylgeraniol, an intermediate product in mevalonate pathway, induces apoptotic cell death in human hepatoma cells: death receptor-independent activation of caspase-8 with down-regulation of Bcl-xL expression. Jpn J Cancer Res2001; 92: 918–25.
19.
JooJHLiaoGCollinsJBGrissomSFJettenAM. Farnesol-induced apoptosis in human lung carcinoma cells is coupled to the endoplasmic reticulum stress response. Cancer Res2007; 67: 7929–36.
20.
LeeSJHaMJLeeJNguyenPChoiYHPirniaFKangWKWangXFKimSJTrepelJB. Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. J Biol Chem1998; 273: 10618–23.
21.
ParkCLeeIKangWK. Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death. Carcinogenesis2001; 22: 1727–31.
22.
ShibataMAKavanaughCShibataEAbeHNguyenPOtsukiYTrepelJBGreenJE. Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models. Carcinogenesis2003; 24: 453–9.
23.
RaoSPorterDCChenXHerliczekTLoweMKeyomarsiK. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc Natl Acad Sci U S A1999; 96: 7797–802.
WisemanDAWernerSRCrowellPL. Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21(Cip1) and p27(Kip1) in human pancreatic adenocarcinoma cells. J Pharmacol Exp Ther2007; 320: 1163–70.
26.
MasudaYNakayaMNakajoSNakayaK. Geranylgeraniol potently induces caspase-3-like activity during apoptosis in human leukemia U937 cells. Biochem Biophys Res Commun1997; 234: 641–5.
27.
PolverinoAJPattersonSD. Selective activation of caspases during apoptotic induction in HL-60 cells. Effects of a tetrapeptide inhibitor. J Biol Chem1997; 272: 7013–21.
28.
MasudaYYodaMOhizumiHAiuchiTWatabeMNakajoSNakayaK. Activation of protein kinase C prevents induction of apoptosis by geranylgeraniol in human leukemia HL60 cells. Int J Cancer1997; 71: 691–7.
29.
MasudaYNakayaMAiuchiTHashimotoSNakajoSNakayaK. The mechanism of geranylgeraniol-induced apoptosis involves activation, by a caspase-3-like protease, of a c-jun N-terminal kinase signaling cascade and differs from mechanisms of apoptosis induced by conventional chemotherapeutic drugs. Leuk Res2000; 24: 937–50.
30.
Shibayama-ImazuTSakairiSWatanabeAAiuchiTNakajoSNakayaK. Vitamin K(2) selectively induced apoptosis in ovarian TYK-nu and pancreatic MIA PaCa-2 cells out of eight solid tumor cell lines through a mechanism different from geranylgeraniol. J Cancer Res Clin Oncol2003; 129: 1–11.
31.
BradfuteDLSimoniRD. Non-sterol compounds that regulate cholesterogenesis. Analogues of farnesyl pyrophosphate reduce 3-hydroxy-3-methylglutaryl-coenzyme A reductase levels. J Biol Chem1994; 269: 6645–50.
32.
CorrellCCNgLEdwardsPA. Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem1994; 269: 17390–3.
33.
KellerRKZhaoZChambersCNessGC. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver. Arch Biochem Biophys1996; 328: 324–30.
34.
OwnbySEHohlRJ. Farnesol and geranylgeraniol: prevention and reversion of lovastatin-induced effects in NIH3T3 cells. Lipids2002; 37: 185–92.
35.
HoutenSMSchneidersMSWandersRJWaterhamHR. Regulation of isoprenoid/cholesterol biosynthesis in cells from mevalonate kinase-deficient patients. J Biol Chem2003; 278: 5736–43.
36.
MiquelKPradinesAFavreG. Farnesol and geranylgeraniol induce actin cytoskeleton disorganization and apoptosis in A549 lung adenocarcinoma cells. Biochem Biophys Res Commun1996; 225: 869–76.
SongBLJavittNBDeBose-BoydRA. Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol. Cell Metab2005; 1: 179–89.
39.
BurkeYDStarkMJRoachSLSenSECrowellPL. Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids1997; 32: 151–6.
40.
OhizumiHMasudaYNakajoSSakaiIOhsawaSNakayaK. Geranylgeraniol is a potent inducer of apoptosis in tumor cells. J Biochem (Tokyo)1995; 117: 11–3.
41.
MiquelKPradinesATerceFSelmiSFavreG. Competitive inhibition of choline phosphotransferase by geranylgeraniol and farnesol inhibits phosphatidylcholine synthesis and induces apoptosis in human lung adenocarcinoma A549 cells. J Biol Chem1998; 273: 26179–86.
42.
ChakrabartiREnglemanEG. Interrelationships between mevalonate metabolism and the mitogenic signaling pathway in T lymphocyte proliferation. J Biol Chem1991; 266: 12216–22.
43.
GhoshPMGhosh-ChoudhuryNMoyerMLMottGEThomasCAFosterBAGreenbergNMKreisbergJI. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line. Oncogene1999; 18: 4120–30.
de Moura EspindolaRMazzantiniRPOngTPde ContiAHeidorRMorenoFS. Geranylgeraniol and β-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-κB activation. Carcinogenesis2005; 26: 1091–9.
